DLILA
Live / Applied — Non-final action mailed (as of 01 Nov 2025)
What this means for you
Not registered yet, but its 12 Jun 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99231503
- Mark type
- Stylized text
- Filed
- 12 Jun 2025
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations; therapeutic proteins for use in the treatment of human diseases; Protein arrays for medical diagnosis purposes
- Class 042 — Scientific and technological services: scientific research in the field of proteomics; pharmaceutical drug development services; pharmaceutical research services; provision of information and data relating to medical and pharmaceutical research and development; medical research; biological research
Owner
- Lila Biologics, Inc., Seattle, WA, US
Prosecution history
- 23 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 23 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 01 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Nov 2025 — NON-FINAL ACTION E-MAILED
- 01 Nov 2025 — NON-FINAL ACTION WRITTEN
- 01 Nov 2025 — ASSIGNED TO EXAMINER
- 20 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 12 Jun 2025 — NEW APPLICATION ENTERED